Junshi Biosciences a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced that the company has established a joint venture with Immorna, a fast-growing biotechnology company focusing on the process development and optimization of mRNA and delivery vehicles and the research and development of new nucleic acid drugs, to develop and commercialize new drugs for the global market in the fields of cancer, infectious diseases, rare diseases, and other diseases, based on the mRNA te

Roche announced that Japans Ministry of Health, Labour and Welfare has approved Ronapreve  casirivimab and imdevimab, for the treatment of patients with mild to moderate COVID-19 via intravenous infusion. The antibody combination was granted a Special Approval Pathway under article 14-3 of the Pharmaceuticals and Medical Devices Act.

Integra Life Sciences Holding Corporation a leading global medical technology company announced positive clinical outcomes for PriMatrix Dermal Repair Scaffold for the management of hard to heal diabetic foot ulcers. This study is one of the largest DFU randomized controlled trials ever completed with more than 100 patients per treatment group and demonstrated that in most cases, one application of PriMatrix plus standard of care healed 60% of DFUs in 12 weeks versus 35% of DFUs that healed in 12 weeks with SOC for the per protocol analysis.

PLx Pharma Inc a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard drug delivery platform to provide more effective and safer products, with its lead products VAZALORE 325 mg and VAZALORE 81 mg ,referred to together as VAZALORE, announced that three stock-keeping units of VAZALORE, the first and only U.S. Food and Drug Administration approved liquid-filled aspirin capsules, will be available in over 8,000 Walgreens stores nationwide later in August. Walgreens is a global leader in retail pharmacy.

Advertisement for District/Divisional/UT Cadre posts of Indenting Department under provisions of the Jammu & Kashmir Civil Services – Decentralization and Recruitment Act, 2010 and rules made thereunder read with other relevant rules governing the subject.

For the benefit of corona patients in Coimbatore Government Medical College and Corona Treatment Center for a period of 6 months on temporary pay basis, Application are invited for Post of Pharmacist.

Post : Pharmacist

No of Posts : 06
Qualification : D.Pharm
Salary : Rs 12,000/- pm

District Health Society, Reasi is going to establish Pradhan Mantri Bhartiya Jan Aushadhi Kendra (PMBJAK) at District Hospital Reasi, Block Katra, Mahore & Pouni with the objective to make available quality generic medicines at affordable prices to all, particularly the poor and disadvantaged, through exclusive outlets “Pradhan Mantri Bhartiya Jan Aushadhi Kendra’s”, so as to reduce pocket expenses in healthcare. In this regard, District Health Society Reasi intends to hire Registered Pharmacists (as per Central Act i.e.

Institute of Life Sciences (ILS), Bhubaneswar, an autonomous institute of the Department of Biotechnology, Ministry of Science and Technology, Government of India invites applications from Indian Nationals to join in the following Project position.

Post: Project Associates - 2 posts

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology (DBT), Ministry of Science and Technology, Govt. of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster (NCR BSC) located at Faridabad, and is designed with the mission to conduct innovative translational research to translate concepts into products to improve human health.

Shree Dhanvantary Pharmacy College is pioneer educational institute and research centre in south Gujarat region. The institute is located in the sprawling campus of 8.32 acres, in Kim. Shree Dhanvantary Pharmacy College has built its own credentials in a short span of 10 years.

Post : Professor / Assistant Professor - Pharmaceutics

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility – single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments. SMS was given the export house status in the year 1997-98. SMS is currently a listed company having ever appreciating international and domestic customer base.

H. R. Patel Institute of Pharmaceutical Education and Research ,formerly known as H. R. Patel Womens' College of Pharmacy, a constitute unit of the Shirpur Education Society, Shirpur marks the beginning of a new era- technical Education for women so to speak in the education spectrum of Shirpur. It was established by renowned personality with an unparalleled vision and acute foresight, Hon. Amrishbhai R. Patel.

The National Institute of Immunohaematology is one of the premiere research Institutes of the ICMR, located currently in the premises of the KEM hospital, Parel, Mumbai. The centre, which was started by ICMR to solve problems in blood banking, could successfully initiate research in various other related areas of immunohaematology viz. Population Genetics, Biochemical Genetics, Antenatal Serology, Immunology, HLA and Autoimmune Disorders. Dr.H.M.Bhatia and Dr.A.J.Baxi were the main architects behind this initial programme.

AUROBINDO PHARMA LTD is a growing Indian multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations.

Post : Executives

Adenovirus vaccine vectors, such as the ChAdOx1 nCov-19 construct which has risen to prominence as a major vaccine for COVID-19, may generate robust long-term immune system responses, according to scientists from the Universities of Oxford and the Cantonal Hospital St.Gallen, Switzerland.

Writing in the journal Nature Immunology, they detail an investigation into one of the key features of adenovirus vaccines – their ability to generate strong and sustained populations of the ‘killer’ T-cell element of the immune system.

Improvisation of the Pharmacopeia and capacity building with CSIR and IITs are the major focus areas for promoting Innvoations in AYUSH Sector said by Dr. Manoj Nesari, Advisor, Ministry of AYUSH, Govt. of India.

AYUSH Committee, PHDCCI organized a Webinar on Innovation & Entrepreneurship in AYUSH Sector- Role of Industry and Govt. of India on 15th July 2021.

BONE THERAPEUTICS the cell therapy company addressing unmet medical needs in orthopedics and other diseases provides an update on its two leading ongoing clinical studies.

These studies are the pivotal Phase III clinical trial with Bone Therapeutics’ enhanced viscosupplement, JTA-004, targeting osteoarthritic knee pain, and the Phase IIb study with its allogeneic cell therapy product, ALLOB, in patients with difficult-to-heal tibial fractures.

Valneva SE a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, and Pfizer Inc announced that they have completed recruitment for the Phase 2 trial, VLA15-221, of Lyme disease vaccine candidate, VLA15. The trial builds on previous positive Phase 2 trials and includes both adult and pediatric participants with the aim to support acceleration of the vaccine candidate’s pediatric program.

The National Institute of Immunology, New Delhi, is a leading research Institute in India with a long-standing reputation for scientific excellence. The institute is equipped with state-of-the-art infrastructure for pursuing research in immunology and allied sciences. The Institute also imparts vigorous long-term research training leading to a Ph.D degree.

Post : Senior Research Fellow (Project) (One Position only)